Evaluating vaccines for HIV prevention using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
Funded at University of Louisiana at Lafayette · NIH-10788043 · Data updated 2026-11-12
This study is looking at how well new HIV vaccines work by testing them on Rhesus macaques, which helps researchers find ways to better protect people from HIV/AIDS.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2023 |
| Award (this year) | $2,072,034 |
| NIH project number | 75N93020D00008-P00004-759302000004-1 |
| Project ID | NIH-10788043 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV infection who may eventually receive vaccines developed from these studies.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to HIV prevention strategies may not benefit directly from this research.
What this research studies
This research focuses on the use of nonhuman primates to evaluate potential vaccines for HIV/AIDS. The Simian Vaccine Evaluation Units (SVEUs) will provide resources for thorough testing of candidate vaccines, assessing their ability to generate immune responses that can prevent or control viral infections. The program includes the breeding and maintenance of Rhesus macaques, allowing researchers to conduct preclinical studies that inform the development of effective HIV prevention strategies. By utilizing these primate models, the research aims to identify correlates of reduced risk of HIV acquisition and enhance vaccine efficacy.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection in humans.
How similar studies have gone: Previous research using nonhuman primates has shown promise in developing effective vaccines for various viral infections, including HIV.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.